Which populations should be assessed for anal cancer and/or precancer screening?
Tuesday, December 4, 2018
Clinical Session
•
CS 05
•
10:15 AM
>
11:45 AM
•
Which populations should be assessed for anal cancer and/or precancer screening?
•
5B
The literature suggests there are at least four populations that might be considered in order to reduce anal cancer morbidity and mortality through a public health screening program: persons with HIV, HIV-negative but immunocompromised populations, men who have sex with men, and women with a prior history of HPV-associated anogenital disease. Session speakers will address the epidemiology of anal cancer, anal precancers, and anal HPV infection among each of these potential populations in the context of possible anal cancer and/or precancer screening.
10:15 AM
•
CS 05-01
•
Conditions for a public health screening program
>
A.
Alan
NYITRAY
10:30 AM
•
CS 05-02
•
Persons with HIV
>
E.
Elizabeth
CHIAO
10:45 AM
•
CS 05-03
•
MSM: HIV-positive and HIV-negative
>
G.
Gypsyamber
D'SOUZA
11:00 AM
•
CS 05-04
•
Women with prior HPV-associated disease
>
E.
Elizabeth
STIER
11:15 AM
•
CS 05-05
•
Using surrogate measures of anal cancer risk to identify high-risk groups for anal cancer
>
G.
Gary
CLIFFORD
11:30 AM
•
CS 05-06
•
Speakers’ Panel
|